Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases.
Stanford researchers have learned that cancer cells can batter their way into new territory, rather than relying on dissolving chemicals.
In this Stanford Medicine Unplugged essay, Yoo Jung Kim discusses how she learned that it was okay not to know everything as a medical student.
A new paper outlines strategies to promote gender diversity in research teams, which can also generate new questions, techniques and results.
Digital medicine advances prompt call for more study about potential implications and ethical issues for patients and clinicians.
Stanford's WELL for Life programs challenges participants to spend mindfully, in an effort to understand the relationship between well-being and finances.
At a recent conversation hosted by Dean Lloyd Minor, journalist and entrepreneur Jessica Lessin discusses the state of technology and journalism.
Jim Yong Kim shared insights from his experience at the helm of global health and financing organizations at a recent address on campus.
Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.
Empathy is a skill that physicians can learn and, writes Dean Lloyd Minor, it’s definitely a skill worth learning.
Stanford scientists have found that viral infections shaped human genome evolution after interbreeding with Neanderthals 50,000 years ago.
A late-night phone call informed a Stanford doctor that his father was named a chemistry laureate for work that helped others create drugs from antibodies.
Carolyn Bertozzi, the co-director of Stanford's interdisciplinary program ChEM-H, reflects here on the program and her goals for the future.
'Mitotic catastrophe' hampers the ability of aged muscle stem cells to repair damage. Manipulating this process could lead to new therapies for old muscle.
In the second piece in a the Understanding AFib series, physician Randall Stafford examines which patients should use blood thinners.
